TCG Crossover Management’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.41M Hold
2025
Q1
$3.87M Hold
2024
Q4
$3.59M Hold
2024
Q3
$4.59M Buy